Genentech GA45767

Study Name: Genentech GA45767

Phase 1, SLE

Up to 15 LuCIN sites (U.S. and Canada)

Active, Not recruiting

Other News

News Update

Lupus Clinical Research: A New Wave of Innovation 

November 6, 2025
A wave of lupus clinical research advances has been building over the past decade.  Now, it is reaching a crest.  A 2025...
Press Release

Lupus Research Alliance Showcases Research that will Shape Next Generation Treatments at ACR Convergence 2025 

New York, N.Y., October 21, 2025 —  4 original posters to be presented on cell therapy, patient-reported outcomes, innovative recruitment strategies, and clinical...
Press Release

Lupus Research Alliance Applauds U.S. FDA Approval of Gazyva® (Obinutuzumab) for Lupus Nephritis

October 20, 2025
Only Treatment Option to Target Underlying Cause of Serious Lupus Complication, Aiming to Preserve Kidney Function The Lupus Research Alliance...